Mycophenolate mofetil as a successful treatment of corticosteroid-resistant immune checkpoint inhibitor-induced hepatitis

Immune checkpoint inhibitors (ICIs) are now widely used to many malignant diseases, but some patients suffer from immune-related adverse events during or after ICI treatments. The monoclonal antibody infliximab is usually chosen as a salvage treatment to combat corticosteroid-resistant adverse event...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oxf Med Case Reports
Autors principals: Nakano, Kenji, Nishizawa, Masatoshi, Fukuda, Naoki, Urasaki, Tetsuya, Wang, Xiaofei, Mitani, Hiroki, Takahashi, Shunji
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7243717/
https://ncbi.nlm.nih.gov/pubmed/32477577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omaa027
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars